China Sees Flurry Of Activity On Avastin

Innovent’s Biosimilar Bevacizumab Approved As Bio-Thera And Henlius Advance

 
• By David Wallace
Eye_China_Flag
China has seen an approval for one bevacizumab biosimilar, with others in the pipeline • Source: Shutterstock

More from Biosimilars

More from Products